GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (LSE:0HKE) » Definitions » Price-to-Funds-From-Operations

Novartis AG (LSE:0HKE) Price-to-Funds-From-Operations : (As of May. 11, 2024)


View and export this data going back to . Start your Free Trial

What is Novartis AG Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Novartis AG (LSE:0HKE) Business Description

Industry
Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.